CD19-CAR-T2 Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD19-CAR-T2 Cells, covering 2024-08-20 to 2024-08-20. Get the full timeline:
Most recent: Clinical Trial Update: CD19-CAR-T2 Cells for CD19 Positive B Cell Malignancies [Phase 2]